CE vs PFE · rev $10.28B vs P/E 20, rev $62.58B
Celanese Corporation (CE) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
CE currently screens at market cap $5.92B. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the CE and PFE stock pages for the full models.
Not investment advice.